Changes in the cytokine network and complement parameters during open heart surgery

Interactive Cardiovascular and Thoracic Surgery

Volumn 2, Issue 1, 2003, Pages 19-24

  Risnes, Ivar ^a   Ueland, Thor ^a   Lundblad, Runar ^a   Mollnes, Tom Eirik ^a   Baksaas, Svein Tore ^a   Aukrust, Pål ^a   Svennevig, Jan L ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Cardiopulmonary bypass; Complement; Cytokine; Inflammatory response

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; INFLAMMATION; MALE; OPEN HEART SURGERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

EID: 0344420018     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-9293(02)00088-9     Document Type: Article

References (25)

1. Royston D. The inflammatory response and extracorporeal circulation. J Cardiothorac Vasc Anesth. 11:1997;341-354.
2. Tønnesen E., Christensen V.B., Toft P. The role of cytokines in cardiac surgery. Int J Cardiol Surg. 53:(Suppl):1996;S1-S10.
3. Mellbye O.J., Frøland S.S., Lilleaasen P., Svennevig J.L., Mollnes T.E. Complement activation during cardiopulmonary bypass: comparison between the use of large volumes of plasma and Dextran 70. Eur Surg Res. 20:1988;101-109.
4. Borger M.A., Rao V., Weisel R.D., Ivanov J., Cohen G., Scully H.E., David T.E. Deep sternal wound infection: risk factors and outcomes. Ann Thorac Surg. 65:1998;1050-1056.
5. Damås J.K., Gullestad L., Aukrust P. Cytokines as new treatment targets in chronic heart failure. Curr Control Trials Cardiovasc Med. 2:2001;271-277.
6. Aukrust P., Ueland T., Lien E., Bendtzen K., Muller F., Andreassen A.K., Noroy I., Aass H., Espevik T., Simonsen S., Froland S.S., Gullestad L. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 83:1999;376-382.
7. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol. 18:2000;217-242.
8. Damås J.K., Wæhre T., Yndestad A., Ueland T., Müller F., Eiken H.G., Holm A.M., Halvorsen B., Frøland S.S., Gullestad L., Aukrust P. Stromal cell-derived factor-1α in unstable angina - potential anti-inflammatory and matrix stabilizing effects. Circulation. 106:2002;36-42.
9. Aukrust P., Liabakk N.B., Müller F., Lien E., Espevik T., Frøland S.S. Serum levels of tumor necrosis factor (TNF)α and soluble TNF receptors in human immunodeficiency virus type 1 infection-correlations to clinical, immunologic and virologic parameters. J Infect Dis. 169:1994;420-424.
10. Mollnes T.E., Harboe M. Neoepitope expression during complement activation; A model for detecting antigenic changes in proteins and activation of cascades. Immunologist. 1/2:1993.
11. Mollnes T.E. Analysis of in vivo complement activation. Herzenberg L.A., Weir D.M., Herzenberg L.A., Blackwell C. Weir's handbook of experimental immunology. 5th ed: 1997;78.1-78.8 Blackwell Science, Boston, MA.
12. Spanier T., Tector K., Schwartz G., Chen J., Oz M., Beck J., Mongero L. Endotoxin in pooled pericardial blood contributes to the systemic inflammatory response during cardiac surgery. Perfusion. 15:(5):2000;427-431.
13. Flom-Halvorsen H.I., Ovrum E., Tangen G., Brosstad F., Rindal M.A., Oystese R. Autotransfusion in coronary artery bypass grafting: disparity in laboratory tests and clinical performance. J Thorac Cardiovasc Surg. 118:(4):1999;610-617.
14. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 19:2001;683-765.
15. Opal S.M., Wherry J.C., Grint P. Interleukin-10: potential benefits and possible risks in clinic infectious diseases. Clin Infect Dis. 27:1998;1407-1507.
16. Gogos C.A., Drosou E., Bassaris H.P., Skoutelis A., Ushikubi F., Yuki K., Narumia S., Sugimoto Y., Ichikawa A., Oh-Ishi S. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis. 181:2000;176-180.
17. van der Poll T., Jansen J., Levi M., ten Cate H., ten Cate J.W., van Deventer S.J. Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med. (180):1994;)1985-)1988.
18. Shinomiya S., Naraba H., Ueno A., Utsunomiya I., Maruyama T., Ohuchida S. Regulation of TNFalpha and interleukin-10 production by prostaglandins I (2) and E (2): studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype selective synthetic agonists. Biochem Pharamacol. 61:2001;1153-1160.
19. van der Poll T., Coyle S.M., Barbosa K., Braxton C.C., Lowry S.F. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest. 97:1996;713-719.
20. Li N., Karin M. Is NF-κB the sensor of oxidative stress? FASEB J. 13:1999;1137-1143.
21. Tak P.P., Firestein G.S. NF-kappaB: a key role in inflammatory diseases. J Clin Invest. 107:2001;7-11.
22. Shyy Y.J., Hsieh H.J., Usami S., Chien S. Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium. Proc Natl Acad Sci USA. 91:1994;4678-4682.
23. Tsao P.S., Buitrago R., Chan J.R., Cooke J.P. Fluid flow inhibits endothelial adhesiveness. Nitric oxide and transcriptional regulation of VCAM-1. Circulation. 94:1996;1682-1689.
24. Lazar H.L., Bao Y., Gaudiani J., Rivers S., Marsh H. Total complement inhibition: an effective strategy to limit ischemic injury during coronary revascularization on cardiopulmonary bypass. Circulation. 100:1999;1438-1442.
25. Mollnes T.E. Biocompatibility: complement as mediator of tissue damage and as indicator of incompatibility. Exp Clin Immunogenet. 14:1997;24-29.